Cargando…

Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya

OBJECTIVE: The recent change of treatment policy for uncomplicated malaria from sulfadoxine-pyrime-thamine to artemether-lumefantrine (AL) in Kenya was accompanied by revised malaria diagnosis recommendations promoting presumptive antimalarial treatment in young children and parasitological diagnosi...

Descripción completa

Detalles Bibliográficos
Autores principales: Zurovac, D, Njogu, J, Akhwale, W, Hamer, D H, Larson, B A, Snow, R W
Formato: Texto
Lenguaje:English
Publicado: Blackwell Publishing Ltd 2008
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592476/
https://www.ncbi.nlm.nih.gov/pubmed/18482078
http://dx.doi.org/10.1111/j.1365-3156.2008.02072.x
_version_ 1782161548262768640
author Zurovac, D
Njogu, J
Akhwale, W
Hamer, D H
Larson, B A
Snow, R W
author_facet Zurovac, D
Njogu, J
Akhwale, W
Hamer, D H
Larson, B A
Snow, R W
author_sort Zurovac, D
collection PubMed
description OBJECTIVE: The recent change of treatment policy for uncomplicated malaria from sulfadoxine-pyrime-thamine to artemether-lumefantrine (AL) in Kenya was accompanied by revised malaria diagnosis recommendations promoting presumptive antimalarial treatment in young children and parasitological diagnosis in patients 5 years and older. We evaluated the impact of these age-specific recommendations on routine malaria treatment practices 4–6 months after AL treatment was implemented. METHODS: Cross-sectional, cluster sample survey using quality-of-care assessment methods in all government facilities in four Kenyan districts. Analysis was restricted to the 64 facilities with malaria diagnostics and AL available on the survey day. Main outcome measures were antimalarial treatment practices for febrile patients stratified by age, use of malaria diagnostic tests, and test result. RESULTS: Treatment practices for 706 febrile patients (401 young children and 305 patients ≥5 years) were evaluated. 43.0% of patients ≥5 years and 25.9% of children underwent parasitological malaria testing (87% by microscopy). AL was prescribed for 79.7% of patients ≥5 years with positive test results, for 9.7% with negative results and for 10.9% without a test. 84.6% of children with positive tests, 19.2% with negative tests, and 21.6% without tests were treated with AL. At least one antimalarial drug was prescribed for 75.0% of children and for 61.3% of patients ≥5 years with a negative test result. CONCLUSIONS: Despite different recommendations for patients below and above 5 years of age, malaria diagnosis and treatment practices were similar in the two age groups. Parasitological diagnosis was under-used in older children and adults, and young children were still tested. Use of AL was low overall and alternative antimalarials were commonly prescribed; but AL prescribing largely followed the results of malaria tests. Malaria diagnosis recommendations differing between age groups appear complex to implement; further strengthening of diagnosis and treatment practices under AL policy is required.
format Text
id pubmed-2592476
institution National Center for Biotechnology Information
language English
publishDate 2008
publisher Blackwell Publishing Ltd
record_format MEDLINE/PubMed
spelling pubmed-25924762008-12-04 Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya Zurovac, D Njogu, J Akhwale, W Hamer, D H Larson, B A Snow, R W Trop Med Int Health Short Communication OBJECTIVE: The recent change of treatment policy for uncomplicated malaria from sulfadoxine-pyrime-thamine to artemether-lumefantrine (AL) in Kenya was accompanied by revised malaria diagnosis recommendations promoting presumptive antimalarial treatment in young children and parasitological diagnosis in patients 5 years and older. We evaluated the impact of these age-specific recommendations on routine malaria treatment practices 4–6 months after AL treatment was implemented. METHODS: Cross-sectional, cluster sample survey using quality-of-care assessment methods in all government facilities in four Kenyan districts. Analysis was restricted to the 64 facilities with malaria diagnostics and AL available on the survey day. Main outcome measures were antimalarial treatment practices for febrile patients stratified by age, use of malaria diagnostic tests, and test result. RESULTS: Treatment practices for 706 febrile patients (401 young children and 305 patients ≥5 years) were evaluated. 43.0% of patients ≥5 years and 25.9% of children underwent parasitological malaria testing (87% by microscopy). AL was prescribed for 79.7% of patients ≥5 years with positive test results, for 9.7% with negative results and for 10.9% without a test. 84.6% of children with positive tests, 19.2% with negative tests, and 21.6% without tests were treated with AL. At least one antimalarial drug was prescribed for 75.0% of children and for 61.3% of patients ≥5 years with a negative test result. CONCLUSIONS: Despite different recommendations for patients below and above 5 years of age, malaria diagnosis and treatment practices were similar in the two age groups. Parasitological diagnosis was under-used in older children and adults, and young children were still tested. Use of AL was low overall and alternative antimalarials were commonly prescribed; but AL prescribing largely followed the results of malaria tests. Malaria diagnosis recommendations differing between age groups appear complex to implement; further strengthening of diagnosis and treatment practices under AL policy is required. Blackwell Publishing Ltd 2008-06 /pmc/articles/PMC2592476/ /pubmed/18482078 http://dx.doi.org/10.1111/j.1365-3156.2008.02072.x Text en © 2008 Blackwell Publishing Ltd
spellingShingle Short Communication
Zurovac, D
Njogu, J
Akhwale, W
Hamer, D H
Larson, B A
Snow, R W
Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya
title Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya
title_full Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya
title_fullStr Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya
title_full_unstemmed Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya
title_short Effects of revised diagnostic recommendations on malaria treatment practices across age groups in Kenya
title_sort effects of revised diagnostic recommendations on malaria treatment practices across age groups in kenya
topic Short Communication
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2592476/
https://www.ncbi.nlm.nih.gov/pubmed/18482078
http://dx.doi.org/10.1111/j.1365-3156.2008.02072.x
work_keys_str_mv AT zurovacd effectsofreviseddiagnosticrecommendationsonmalariatreatmentpracticesacrossagegroupsinkenya
AT njoguj effectsofreviseddiagnosticrecommendationsonmalariatreatmentpracticesacrossagegroupsinkenya
AT akhwalew effectsofreviseddiagnosticrecommendationsonmalariatreatmentpracticesacrossagegroupsinkenya
AT hamerdh effectsofreviseddiagnosticrecommendationsonmalariatreatmentpracticesacrossagegroupsinkenya
AT larsonba effectsofreviseddiagnosticrecommendationsonmalariatreatmentpracticesacrossagegroupsinkenya
AT snowrw effectsofreviseddiagnosticrecommendationsonmalariatreatmentpracticesacrossagegroupsinkenya